Cervical cancer vaccine could reduce number of cases from 3,000 to less than 700 every complete year Cervical cancer vaccine ‘may prevent even more cases than initially thought’The cervical cancer vaccine could prevent even more cases of the condition in England than previously thought, UK scientists have discovered. A report by scientists at the Health Protection Company , the University of Manchester and the Manchester Royal Infirmary shows that the vaccine could potentially reduce the amount of cases every year from about 3,000 to significantly less than 700. Earlier studies had recommended that about 70 percent of cases of cervical cancer are due to types 16 or 18 of the individual papillomavirus – against which the current cervical cancers vaccine provides protection. But the latest study, published in the British Journal of Tumor, indicates these two strains of the virus actually cause between 73 percent and 77 percent of cervical cancer cases.Tremendous achievements have been made in trying to develop the best medicines to take care of the affected people. Collectively, the program has an innovative online application and shopping process. Self-service for ongoing expenses presentment, payment and maintenance can be provided for companies and consumers signed up for these plans. Studies show that customers demand a deeper knowledge of the complexities of lifestyle and ancillary items to truly worth what these benefits present. With Benefitfocus solutions, USAble Existence has an increased capability to educate customers about their competitive spectral range of products as the technology provides on-line tools to help customers understand how the huge benefits work.